Considering rump injections? Head to the donut shop instead.
Healthcare providers are being warned about an increased rate of adverse cardiac events, as the agency conducts additional analyses.
The agency states this list of more than 1000 devices doesn’t have risks that warrant premarket notification.
Taking a risk-based approach can help companies safeguard medical devices against exploitation and ensure an effective and secure network.
Don’t overlook this critical practice.
The president’s selection is drawing criticism due to reported ties with the pharmaceutical industry.
Industry experts share advice that could influence company success.
Many companies go for product approval in smaller markets first. Is that the right decision?
You don’t need to tell FDA all the gory details.
As software becomes more complex and connected, device manufacturers must address more risks.